Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Characterization of semen collected by pharmacologically induced ejaculation from a stallion with seminal vesiculitis

Texto completo
Autor(es):
Cavalero, Thais Mendes Sanches [1] ; Segabinazzi, Lorenzo Garrido Teixeira M. [1] ; Scheeren, Veronica Flores da Cunha [1] ; Freitas-Dell'Aqua, Camila P. [1] ; Papa, Frederico Ozanam [1]
Número total de Autores: 5
Afiliação do(s) autor(es):
[1] Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Botucatu, SP - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: REPRODUCTION IN DOMESTIC ANIMALS; v. 55, n. 12 NOV 2020.
Citações Web of Science: 0
Resumo

The present study compared the quality of sperm collected by artificial vagina or pharmacologically induced ejaculation from a 10-year-old thoroughbred stallion with seminal vesiculitis. The pharmacological protocol involved intravenous administration of detomidine (0.01 mg/kg) and oxytocin (20 IU) and successfully induced ejaculation in all attempts of semen collection. Sperm motility, plasma membrane and acrosome integrity (PMAI), reactive oxygen species (ROS) levels, polymorphonuclear neutrophil (PMN) percentage, and bacterial profiles of fresh and cooled semen (5 degrees C for 24 hr) were evaluated. Semen obtained by the pharmacological method presented reduced seminal volume, decreased PMN percentage and superior sperm motility in cooled samples. Moreover, higher PMAI and lower ROS levels were observed in semen collected by the pharmacological method. Therefore, pharmacologically induced ejaculation is an alternative to obtain semen with minimal contamination and with sperm of superior quality and longevity from stallions with seminal vesiculitis. (AU)

Processo FAPESP: 16/21452-5 - Indução farmacológica da ejaculação em garanhões após a administração de diferentes protocolos utilizando detomidina, xilazina e ocitocina
Beneficiário:Frederico Ozanam Papa
Modalidade de apoio: Auxílio à Pesquisa - Regular